Orchid exists to save men's lives from testicular, prostate and penile cancers
through pioneering research and promoting awareness
The first ever official meeting of the UK's Testicular Cancer CNS's was held in Birmingham. Presentations throughout the day included latest research outcomes from the 111 trial and supportive care on chemotherapy by Professor Michael Cullen, The changing role of the Cancer Nurse Specialist by Jane Robson, The prevalence and role of androgen deficiency in young male cancer survivors by Dr Diana Greenfield and Survivorship by Sue Brand. Nurse led workshops were held though out the afternoon where CNS's could share experiences and discuss patient pathways and best practice Orchid staff member Natalie Lamb presented information on Orchid's current work and future plans.
Organisers Zoe O'Neill, Germ Cell Clinical Nurse Specialist, University Hospitals Coventry & Warwickshire NHS Trust and Paul Hutton, CNS testicular cancer, University Hospital Birmingham commented "Paul and I were delighted with the turn out and everyone’s in put to the day. We received many e-mails with very positive feedback. Most people got a lot from the day it was fantastic to be involved in bringing us all together for the first time. It will become an annual event it is the perfect opportunity to network and share good practice. Your input was fantastic it is great to find out what orchid are doing to raise awareness and the future plans to expand and employ the nurse to support male cancer patients."
Click here to view the full programme of the day.
The Beatson West of Scotland Cancer Centre hosted a highly successful national testicular cancer meeting at the Beatson Laboratories, where specialists in treating the disease met to share their latest research findings and to discuss best practice. The event was chaired by Dr Jeff White and Dr Ashita Waterston and attended by 60 delegates from across the globe including oncologists, urologists, clinical nurse specialists and representatives from specialist charities including Orchid.
The day marked the introduction of the revised SIGN (The Scottish Intercollegiate
Guidelines Network) Guideline 124 – Management of adult testicular germ cell tumours. This document provides recommendations for best practice in the management of testicular cancer (http://www.sign.ac.uk/pdf/sign124.pdf) for the NHS in Scotland and is regarded worldwide as a source of high quality evidence. During the meeting speakers highlighted the treatment options including high dose chemotherapy and surgery, monitoring and investigations with tumour markers and PET-CT. The keynote lecture was delivered by Professor Sophie Fossa, from The Norwegian Radium Hospital, University of Oslo and covered potential effects of treating the disease and the issue of tracking survivors on a life-time basis. There were presentations on the special issues of Teenagers and young adults with this disease and the holistic support that is provided by clinical nurse specialists to the patients and families affected by the disease.
Orchid representative Nicola Broad provided attendees with valuable information regarding the services and information Orchid offers free of charge to themselves and their patients. She was able to meet with healthcare professionals working within the areas of both testicular and penile cancer.
![]()
Orchid works closely with BAUN and has been invited to attend some of their regional conferences. Orchid is becoming a leader in providing information on the male cancers to healthcare professionals and their patients, especially as a provider of penile cancer material.
Over 100 delegates attended the event at The Clarendon Suites in Birmingham. The study day was aimed at urology and oncology nurses working in both the community and the acute sector, as well as nursing professionals with an interest in the management & treatment of prostate cancer. The day was chaired by BAUN President – Lucinda Poulton
and speakers invited included Dr. Daniel Ford, Consultant Oncologist, City Hospital, Mr. John Parkin, Consultant Urologist, Sandwell Hospital, Richard Gledhill, Prostate Cancer CNS, Queen Elizabeth Hospital and many other high profile speakers.
Orchid provided an information stand in the exhibition area allowing attendees to view the growing number of leaflets, factsheets, posters and flyers on the male cancers, especially prostate cancer. Healthcare professionals requested resources to be sent to their workplace and were keen to join Orchid's newsletter mailing list to be kept up to date with our work.
The annual event was held in Harrogate in the North of England and attended by 200 delegates. A number of talks were held in two lecture theatres centered around urology and oncology topics. Much of the last day focused on penile cancer. Speakers highlighted the lack of written material available on penile cancer. Urological nurses were keen to be informed that Orchid supplied its penile cancer leaflet free of charge to patient and healthcare professionals. With more factsheets planned for 2011 Orchid is fast becoming the leader in providing information on penile cancer in the UK.
European Organisation for Research and Treatment of Cancer Conference
EORTC held a two day conference at Butchers Hall, St Bart's Hospital and invited Orchid to hold a display stand in the entrance to inform European healthcare professionals of our successful work in the UK.